ESTUDIO WHI, REVISTA DE MENOPAUSIA, SALUD, REVISTAS MÉDICAS. Actualidad Inmediata Debido a la importancia de esta investigación y al impacto en. WHI. Progestin. Estrogen. Tibolone. Cardiovascular disease. Tromboembolic disease . Boletín de la Asociación Española para el Estudio de la Menopausia, . Los trastornos de la menopausia pueden ser evitados y combatidos Sin embargo, recientes estudios, como el estudio WHI, han puesto en duda los beneficios.

Author: Taunris Voodoolar
Country: Papua New Guinea
Language: English (Spanish)
Genre: Sex
Published (Last): 13 February 2014
Pages: 182
PDF File Size: 18.57 Mb
ePub File Size: 3.19 Mb
ISBN: 676-7-91575-228-6
Downloads: 75575
Price: Free* [*Free Regsitration Required]
Uploader: Bajin

Nutr Cancer, 26pp.


The Millennium Review, Parthenon Risks and benefits of estrogen plus progestin in healthy postmenopausal women. The Management of the Menopause.

Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors: La primera es el papel potencial de los diferentes preparados hormonales versus los efectos cognitivos adversos relacionados por ej. When hormone replacement therapy is not possible.

Influence of estrogen plus progestin on breast cancer and mammography in healty postmenopausal women. Failure of estrogen plus progestin therapy for prevention.

Impacto del estudio WHI en pacientes y medicos. Amer J Clin Nutr, 78pp. Fertil Steril, 77pp. Strengths of WHIMS-Y include balance in baseline risk factors between treatment groups, wni and masked data collection, and high rates of retention and on-trial adherence and exposure.

There was a problem providing the content you requested

Postmenopausal hormone therapy and the risk of cardiovascular disease: It would suggest that if women were treated during one year there would be less than one woman with an adverse effect. Obst Gynecol, 87pp. Phytoestrogens supplements estudi the treatment of hot flashes: The effect of isoflavones extracted from red clover Rimostil on lipid and baile metabolism.

TOP Related Articles  BIR FORM 1904 PDF

Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine in the perimenopausal women. Serum enterolactone concentration is not associated with breast cancer risk menopauwia a nested casecontrol study.

Maturitas, 45pp. Risk and benefits of estrogen plus progestin in healty postmenopausal women. Phytoestrogens do setudio influence lipoprotein levels or endothelial function in healthy postmenopausal women.

The second was whether hormone use by younger postmenopausal women near the time of menopause reduces dementia risk or whether WHIMS findings should be generalized to younger women.

Results from WHI and HERS II – Implications for women and the prescriber of HRT

Obstet Gynecol,pp. These cancers were invasive. Pooling data for estrogen alone and estrogen plus progestin resulted in increased risks for both endpoints.

High quality observational studies may extend evidence over a wider population and are likely to be dominant in the identification of harms [ 8 ].

Urinary excretion of phytoestrogens and risk of breast cancer among Chinese women in Shangai. In addition, the telephone-administered cognitive battery showed adequate construct validity. Trifolium pratense red clover exhibits estrogenic effects in vivo in ovariectomized Spragne-Dawley rats. Trends in the incidence of coronary heart disease and changes in diet and lifestyle in women.

Am J Cardiol ; 90 1 Supl. It must be emphasized that the WHI report stresses that the results do not necessarily apply to lower dosages of those drugs, to other formulations of oral estrogen and progestin or to estrogens and progestins administered through the transdermal route [ 1 ].

Hu FB, Grodstein F. Our main goal, as attending physicians of postmenopausal women, is the maintenance of their health and the primary and secondary prevention of the diseases, which are more prevalent after age 50 [ 13 ]. We present the study rationale and design.


Annals de Medicina, 87pp. Efficacy of a soy rich diet in preventing postmenopausal qhi. The estrogen-alone data were published in and were summarized once again in two separate papers [4,5]: Remember the CACS study, an open coronary calcification study that was started after the termination of the estrogen-alone arm trial, when it became evident that the younger WHI age group might have benefited from therapy.

Press Conference Remarks July 9, Several years later, data from an extension trial of up to 4 additional years after discontinuation of HT were released [6]: Principal results from the Women’s Health Initiative controlled randomized trial. Beneficial effects of soy phytoestrogen intake in postmenopausal women with type 2 diabetes. J Nutr,pp. Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: However, we all have learnt now to be ever more cautious in discussing risks and benefits of estrogen and progestin treatment.

The WHI safety committee [ 1 and 2 ] decided to interrupt one arm of the study because women on the combined estrogen-progestin, at the end 5.

Estrogen plus progestin and the risk of coronary heart disease.